| 1 |
28598549 | The presence of minocycline in the tear film of normal horses following oral administration and its anticollagenase activity. | 2018 Jan |
1 |
| 2 |
24125013 | Structural and dynamics analysis of matrix metalloproteinases MMP-2 complexed with chemically modified tetracyclines (CMTs). | 2014 Dec |
2 |
| 3 |
23121406 | Chemically modified tetracyclines as inhibitors of MMP-2 matrix metalloproteinase: a molecular and structural study. | 2012 Nov 26 |
3 |
| 4 |
21689755 | Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases. | 2011 Dec |
1 |
| 5 |
18673015 | Host-response therapeutics for periodontal diseases. | 2008 Aug |
1 |
| 6 |
16953823 | Chemically modified tetracyclines stimulate matrix metalloproteinase-2 production by periodontal ligament cells. | 2006 Oct |
2 |
| 7 |
14508231 | Minocycline inhibits smooth muscle cell proliferation, migration and neointima formation after arterial injury. | 2003 Oct |
1 |
| 8 |
9972128 | Tetracycline-based MMP inhibitors can prevent fibroblast-mediated collagen gel contraction in vitro. | 1998 Nov |
2 |
| 9 |
7978787 | Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes. | 1994 Sep 6 |
2 |
| 10 |
1425210 | Tetracycline inhibition identifies the cellular sources of collagenase in gingival crevicular fluid in different forms of periodontal diseases. | 1992 |
1 |